-
Levodopa (L-DOPA)
- PARKINSONS
- Increases DAPoor bioavailability (97% metabolized in periphery)
-
Carbidopa
- PARKINSONS
- Blocks levodopa conversion into DA in periphery
- Allows levodopa to pass BBB
- Carbidopa cannot pass BBB itself, otherwise it would breakdown levodopa there too
-
Entacapone
- PARKINSONS
- COMT Inhibitor
- Increase amount of L-DOPA available to DA neurons by decreasing metabolism in periphery
- Useful against on/off syndrome
-
Selegiline
- PARKINSONS
- MAOB selective inhibitor
-
Rasagiline
- PARKINSONS
- MAOB selective inhibitor
- May slow the progression of Parkinson's
-
Ropinirole
- PARKINSONS
- Dopamine receptor agonist
-
Haloperidol
- SCHIZOPHRENIA
- First generation anti-psychotic medication
- Blocks D2-like Rs
-
Clozapine
- SCHIZOPHRENIA
- Blocks serotonin and D2-like Rs
- Most effective antipsychotic available
-
Olanzapine
- SCHIZOPHRENIA
- 2nd generation anti-psychotic
- Designed to target Serotonin Rs
- Also blocks D2-like DA Rs
-
Quetiapine
- SCHIZOPHRENIA
- 2nd generation anti-psychotic
- Designed to target Serotonin Rs
- Also blocks D2-like DA Rs
-
Nicotine Replacement
- TOBACCO USE
- Not very effective
-
Varenicline
- TOBACCO USE
- Nicotinic receptor partial agonistLonger, sustained increase of DA
-
Bupropion
- TOBACCO USE
- Inhibits the uptake of monoaminesStabilize dopamine levels following tobacco withdrawal
-
Methadone
- OPIATE ABUSE
- Mu opioid R agonistPreventing withdrawal
- Transfer dependence/addiction to methadone
-
Clonidine
- OPIATE ABUSE
- Decrease activity by stimulating a2 receptor (autoreceptor)Inhibit release of ACh
- Decrease the severity of withdrawal by decreasing ACh
-
Naltrexone
- OPIATE ABUSE
- Opioid antagonistGenerate rapid and severe withdrawal stateAnesthesia usually administered too
-
Buprenorphine
- OPIATE ABUSE
- Partial agonist
Promotes tolerance - Prevents rapid on-off activation of reward mediator
- Harder to reach a high/euphoria
-
Diazepam
- ALCOHOL ABUSE
- Depresses CNS activityLong-acting sedative
-
Carbamazepine
- ALCOHOL ABUSE
- Depresses CNS activity
-
Disulfiram
- ALCOHOL ABUSE
- Blocks acetaldehyde dehydrogenaseResults in flushing, nausea, headache, dysphoria
-
Naltrexone
- ALCOHOL ABUSE
- Opioid receptor antagonistBlocks endogenous reward system
-
Acamprosate
- ALCOHOL ABUSE
- Blocks glutamate receptors
- Reduces craving, doesn't prevent withdrawal
-
-
-
-
Flumazenil
- ANXIETY
- Benzodiazepine antagonist
-
-
-
Zolpidem
- ANXIETY
- Exhibit affinity for a1 containing GABAA Rs
- Increases sleep time
- Short half life
- More restricted than BZD
-
Zaleplon
- ANXIETY
- Exhibit affinity for a1 containing GABAA RsIncreases sleep time
- Short half life
- More restricted than BZD
-
Buspirone
- ANXIETY
- Serotonin Partial AgonistDecreases firing rate of 5-HT neurons
- Used to treat situational anxiety, generalized
-
-
Clonidine
- ANXIETY
- a2 receptor agonistStimulating an autoreceptor
- Suppresses Sympathetic NS
-
Propanolol
- ANXIETY
- Beta (B1 & B2) receptor antagonist
- Reduces Sympathetic NS activity
- ****Drug that interacts with benzos
-
Alcohol
****Drug that interacts with benzos
-
Fluoxetine
****Drug that interacts with benzos
-
Fluvoxamine
****Drug that interacts with benzos
-
Paroxetine
****Drug that interacts with benzos
-
Phenylephrine
a1 receptor selective AGONIST
-
Prazosin
a1 receptor selective ANTAGONIST
-
Terazosin
a1 receptor selective ANTAGONIST
-
Tamsulosin
a1 receptor selective ANTAGONIST
-
Dobutamine
B1 receptor selective AGONIST
-
Albuterol
B2 receptor selective AGONIST
-
Atenolol
- B1 receptor selective ANTAGONIST
- cardioselective
-
Acebutolol
B1 receptor selective partial agonist (has ISA)
-
Pilocarpine
- CHOLINERGIC DIRECT ACTING
- Muscarinic receptor agonist
-
Bethanechol
- CHOLINERGIC DIRECT ACTING
- Muscarinic receptor agonist
-
Atropine
- CHOLINERGIC DIRECT ACTING
- Muscarinic receptor antagonist (antimuscarinic)
-
Scopolamine
- CHOLINERGIC DIRECT ACTING
- Muscarinic receptor antagonist (antimuscarinic)
-
Ipratropium
- CHOLINERGIC DIRECT ACTING
- Muscarinic receptor antagonist (antimuscarinic)
-
Tolterodine
- CHOLINERGIC DIRECT ACTING
- Muscarinic receptor antagonist (antimuscarinic)
-
Physostigmine
- CHOLINERGIC INDIRECT ACTING
- Anticholinesterase (Reversible)
-
Organophosphates
- CHOLINERGIC INDIRECT ACTING
- Anticholinesterase (Irreversible)
-
Botox
- CHOLINERGIC INDIRECT ACTING
- Acetylcholine Release Inhibitor
|
|